Click Therapeutics

Click Therapeutics, Inc. is a New York-headquartered digital medicine company founded in 2012 by David Benshoof Klein that develops, validates, and commercializes software as prescription medical treatments — the category it named Digital Therapeutics. Its AI-enabled platform targets diseases with an underlying neurological or behavioral component through cognitive and neurobehavioral mechanisms, delivered as smartphone software used independently or alongside biomedical therapy (Software-Enhanced Drugs). Authorized and commercial programs include CT-152 (Rejoyn, major depressive disorder, developed with Otsuka), CT-132 (episodic migraine) and AspyreRx (type 2 diabetes), with a pipeline spanning schizophrenia (CT-155 with Boehringer Ingelheim, CT-156), opioid use disorder, multiple sclerosis, atopic dermatitis, obesity, oncology, insomnia and acute coronary syndrome. Click publishes no public developer program, API, or SDK — its software is distributed as regulated prescription therapeutics, not as a platform.

Click Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Health, Healthcare, Digital Therapeutics, and Prescription Digital Therapeutics.

Click Therapeutics’ developer surface includes engineering blog, support, and 13 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.7/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-05 · rubric v0.9.1

0 APIs

CompanyHealthHealthcareDigital TherapeuticsPrescription Digital TherapeuticsMedical DevicesMental HealthLife SciencesSoftware as a Medical Device

Kin Score

Kin Score How this is scored →
scored 2026-08-05 · rubric v0.9.1

Composite quality — 13.7/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.9 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/click-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

Blog

Press

LinkedIn

Careers

Careers

Investors

Investors

Scroll for all 7

Other 2

Properties that don't map to a standard resource type

Products

Products

Platform

Platform

Source (apis.yml)

aid: click-therapeutics
name: Click Therapeutics
description: Click Therapeutics, Inc. is a New York-headquartered digital medicine company founded in 2012 by David Benshoof
  Klein that develops, validates, and commercializes software as prescription medical treatments — the category it named Digital
  Therapeutics. Its AI-enabled platform targets diseases with an underlying neurological or behavioral component through cognitive
  and neurobehavioral mechanisms, delivered as smartphone software used independently or alongside biomedical therapy (Software-Enhanced
  Drugs). Authorized and commercial programs include CT-152 (Rejoyn, major depressive disorder, developed with Otsuka), CT-132
  (episodic migraine) and AspyreRx (type 2 diabetes), with a pipeline spanning schizophrenia (CT-155 with Boehringer Ingelheim,
  CT-156), opioid use disorder, multiple sclerosis, atopic dermatitis, obesity, oncology, insomnia and acute coronary syndrome.
  Click publishes no public developer program, API, or SDK — its software is distributed as regulated prescription therapeutics,
  not as a platform.
image: https://clicktherapeutics.imgix.net/images/seo-share-image.png
url: https://raw.githubusercontent.com/api-evangelist/click-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-public-api
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Health
- Healthcare
- Digital Therapeutics
- Prescription Digital Therapeutics
- Medical Devices
- Mental Health
- Life Sciences
- Software as a Medical Device
apis: []
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 3
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.clicktherapeutics.com/
- type: About
  url: https://www.clicktherapeutics.com/about
- type: Blog
  url: https://www.clicktherapeutics.com/insights
- type: Press
  url: https://www.clicktherapeutics.com/news
- type: Products
  url: https://www.clicktherapeutics.com/products
- type: Platform
  url: https://www.clicktherapeutics.com/platform
- type: Support
  url: https://www.clicktherapeutics.com/contact
- type: TermsOfService
  url: https://www.clicktherapeutics.com/terms-of-use
- type: PrivacyPolicy
  url: https://www.clicktherapeutics.com/privacy-policy
- type: GitHubOrganization
  url: https://github.com/clicktherapeutics
- type: LinkedIn
  url: https://www.linkedin.com/company/click-therapeutics-inc-
- type: Careers
  url: https://www.clicktherapeutics.com/careers
- type: Investors
  url: https://forgeglobal.com/click-therapeutics_stock/
- type: DomainSecurity
  url: security/click-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/click-therapeutics-llms.txt